Ligand validation:1NUX

F6P: 6-O-phosphono-beta-D-fructofuranose

F6P is a Ligand Of Interest in 1NUX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1NUX_F6P_A_2339	98%	59%	0.056	0.979	0.64	0.91	-	-	0	0	100%	1
1NUW_F6P_A_2336	98%	59%	0.064	0.987	0.63	0.95	-	1	0	0	100%	1
1CNQ_F6P_A_339	95%	44%	0.077	0.98	0.99	1.17	-	1	0	0	100%	1
1LEV_F6P_F_338	94%	55%	0.075	0.976	0.7	1.03	-	1	0	0	100%	1
1NV3_F6P_A_2339	93%	66%	0.085	0.981	0.55	0.77	-	-	0	0	100%	1
1NUY_F6P_A_2339	93%	59%	0.079	0.974	0.66	0.9	-	1	1	0	100%	0.9375
5HR5_F6P_A_602	99%	59%	0.064	0.991	0.94	0.64	1	-	0	0	100%	1
6HVI_F6P_A_603	97%	53%	0.071	0.986	0.8	1.03	1	1	0	0	100%	1
4R74_F6P_D_401	96%	38%	0.074	0.984	1.57	0.87	4	-	0	0	100%	15
5HTK_F6P_A_604	96%	42%	0.081	0.989	1.25	1.01	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.